These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Circulation; 1996 Feb 15; 93(4):781-91. PubMed ID: 8641008 [Abstract] [Full Text] [Related]
4. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M. Circulation; 1994 Mar 15; 89(3):1237-46. PubMed ID: 8124812 [Abstract] [Full Text] [Related]
6. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H, Kuzuya T, Takeda H, Hori M. J Am Coll Cardiol; 1999 Dec 15; 34(7):2120-5. PubMed ID: 10588233 [Abstract] [Full Text] [Related]
8. Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts. Kitakaze M, Node K, Asanuma H, Takashima S, Sakata Y, Asakura M, Sanada S, Shinozaki Y, Mori H, Kuzuya T, Hori M. Circ Res; 2000 Aug 18; 87(4):303-8. PubMed ID: 10948064 [Abstract] [Full Text] [Related]
10. Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Node K, Kitakaze M, Minamino T, Tada M, Inoue M, Hori M, Kamada T. Br J Pharmacol; 1997 Jan 18; 120(2):273-81. PubMed ID: 9117120 [Abstract] [Full Text] [Related]
11. Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning. Wolff G, Truse R, Decking U. PLoS One; 2015 Jan 18; 10(8):e0135086. PubMed ID: 26261991 [Abstract] [Full Text] [Related]
12. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M. Circulation; 2004 Jun 08; 109(22):2773-9. PubMed ID: 15148268 [Abstract] [Full Text] [Related]
14. Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Circulation; 1993 Jan 08; 87(1):208-15. PubMed ID: 8419009 [Abstract] [Full Text] [Related]
16. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning. Node K, Kitakaze M, Sato H, Minamino T, Komamura K, Shinozaki Y, Mori H, Hori M. Circulation; 1997 Aug 19; 96(4):1257-65. PubMed ID: 9286957 [Abstract] [Full Text] [Related]
18. Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart. Kitakaze M, Minamino T, Funaya H, Node K, Shinozaki Y, Mori H, Hori M. Circulation; 1997 Apr 15; 95(8):2108-14. PubMed ID: 9133521 [Abstract] [Full Text] [Related]